Inventiva S.A. Sponsored ADR

IVA Healthcare Biotechnology

Inventiva S.A. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $9.0 million, down 43.7% from fiscal 2024.

2.94 0.17 −5.47%
Market cap
$740.0M
P/E
0.0×
Fwd P/E
−4.6×
Dividend yield
—
F-score
4/9
Altman Z
−1.36
Beneish M
−7.91
Dividend safety
n/a
Older periods Jun '23 Jun '24 Jun '25 Jun '26
ROE

+8 more TTM periods

(299.62%) 0.00% 0.00% 0.00%
ROA
(134.83%) 0.00% 0.00% 0.00%
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(611.61%) 0.00% 0.00% 0.00%
Average Days of Receivables
134.41 0.00 0.00 0.00
Free Cash Flow per Share
0.00 0.00 0.00 —
Free Cash Flow
(128.69) (105.47) (137.54) —
Capital Expenditures
(0.52) (0.65) (0.64) —
Other line items
Cash ROIC
(201.04%) 599.34% (71.14%) 0.00%
Accounts Receivable Turnover
3.65 0.00 0.00 0.00
Accounts Payable Turnover
0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 — —
Average Days of Payables
0.00 0.00 0.00 0.00
Days of Inventory on Hand
0.00 0.00 — —
Tax Rate
(0.08) — — —
Research and Development Expense of Revenue
777.68% — — —
Selling, General and Administrative Expense of Revenue
152.29% — — —
Share Based Compensation of Revenue
0.00% 0.00% 0.00% —
Interest Coverage
0.00 — — —
Operating CF/Net income
0.87 0.00 0.00 —
Depreciation/Fixed assets
0.42 0.49 1.62 0.00
Capex/Depreciation
(0.15) (0.16) (0.09) —
Revenue per Share
0.00 — — —
Operating CF per Share
0.00 0.00 0.00 —
Capex per Share
0.00 0.00 0.00 —
Capex to Sales
0.03 0.00 0.00 —

Fold the line items

Columns are period end dates · fundamentals updated 30 Sep 2026